Morbidity and mortality outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy at a single tertiary institution: Towards a new perspective of this treatment

Annals of Surgery

Volumn 251, Issue 1, 2010, Pages 101-106

  Chua, Terence C ^a   Saxena, Akshat ^a   Schellekens, J F ^a   Liauw, Winston ^a   Yan, Tristan D ^a   Fransi, Sal ^a   Zhao, Jing ^a   Morris, David L ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; CISPLATIN; DOXORUBICIN; FLUOROURACIL; HEPARIN; METRONIDAZOLE; MITOMYCIN C; ANTINEOPLASTIC AGENT;

ABDOMINAL DISEASE; ADULT; AGED; ARTICLE; BILE LEAKAGE; CANCER CHEMOTHERAPY; CANCER SURGERY; CARCINOMATOUS PERITONITIS; CHOLECYSTECTOMY; COLON RESECTION; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DIGESTIVE SYSTEM CANCER; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; FISTULA; HEART ARRHYTHMIA; HUMAN; HYSTERECTOMY; ILEUS; KIDNEY DYSFUNCTION; LENGTH OF STAY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OPERATION DURATION; OUTCOME ASSESSMENT; OVARY CANCER; PERFORATION; PERIOPERATIVE PERIOD; PERITONEUM CANCER; PERITONEUM MESOTHELIOMA; PERITONEUM PSEUDOMYXOMA; PERITONEUM TUMOR; PLEURA EFFUSION; PNEUMONIA; PNEUMOTHORAX; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; SIGMOIDECTOMY; SMALL INTESTINE OBSTRUCTION; SMALL INTESTINE RESECTION; SPLENECTOMY; SURGICAL MORTALITY; SURGICAL TECHNIQUE; ELECTROSURGERY; INFUSION; METASTASIS; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PERITONEUM; PERITONEUM LAVAGE; SURVIVAL RATE; VISCERA;

ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; ELECTROSURGERY; FEMALE; HUMANS; INFUSIONS, PARENTERAL; MALE; MIDDLE AGED; PERITONEAL LAVAGE; PERITONEAL NEOPLASMS; PERITONEUM; POSTOPERATIVE COMPLICATIONS; SURVIVAL RATE; VISCERA;

EID: 74049090383     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181b5ae43     Document Type: Article

References (30)

1. Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995;221:29-42.
2. Cavaliere F, Valle M, De Simone M, et al. 120 peritoneal carcinomatoses from colorectal cancer treated with peritonectomy and intra-abdominal che-mohyperthermia: a S.I.T.I.L.O. multicentric study. In Vivo. 2006;20:747-750.
3. Gusani NJ, Cho SW, Colovos C, et al. Aggressive surgical management of peritoneal carcinomatosis with low mortality in a high-volume tertiary cancer center. Ann Surg Oncol. 2008;15:754-763.
4. Smeenk RM, Verwaal VJ, Zoetmulder FAN. Learning curve of combined modality treatment in peritoneal surface disease. Br J Surg. 2007;94:1408-1414.
5. Kusamura S, Younan R, Baratti D, et al. Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique. Cancer. 2006;106:1144-1153.
6. Glehen O, Osinsky D, Cotte E, et al. Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures [comment]. Ann Surg Oncol. 2003;10:863-869.
7. Sugarbaker PH, Alderman R, Edwards G, et al. Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy. Ann Surg Oncol. 2006;13:635-644.
8. Yan TD, Links M, Fransi S, et al. Learning curve for cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal surface malig-nancy-a journey to becoming a Nationally Funded Peritonectomy Center. Ann Surg Oncol. 2007;14:2270-2280.
9. Verwaal VJ, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21:3737-3743.
10. Esquivel J, Nissan A, Stojadinovic A. Cytoreductive surgery and heated intra-peritoneal chemotherapy in the treatment of peritoneal carcinomatosis of colorectal origin: the need for practice altering data. J Surg Oncol. 2008;98: 397-398.
11. Chua TC, Liauw W, Robertson G, et al. Towards randomized trials of cytoreductive surgery using peritonectomy and hyperthermic intraperitoneal chemotherapy for ovarian cancer peritoneal carcinomatosis. Gynecol Oncol. 2009;114:137-139.
12. Yan TD, Black D, Savady R, et al. Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma. J Clin Oncol. 2006;24:4011-4019.
13. Bijelic L, Jonson A, Sugarbaker PH. Systematic review of cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis in primary and recurrent ovarian cancer. Ann Oncol. 2007;18:1943-1950.
14. Glehen O, Kwiatkowski F, Sugarbaker PH, et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol. 2004;22:3284-3292.
15. Yan TD, Welch L, Black D, et al. A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma. Ann Oncol. 2007; 18:827-834. (Pubitemid 47054078)
16. Yan TD, Black D, Savady R, et al. A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei. Ann Surg Oncol. 2007;14:484-492. (Pubitemid 46175292)
17. Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res. 1996; 82:359-374.
18. Kulig J, Popiela T, Kolodziejczyk P, et al. Standard D2 versus extended D2 (D2+) lymphadenectomy for gastric cancer: an interim safety analysis of a multicenter, randomized, clinical trial. Am J Surg. 2007;193:10-15.
19. Yonemura Y, Wu CC, Fukushima N, et al. Operative morbidity and mortality after D2 and D4 extended dissection for advanced gastric cancer: a prospective randomized trial conducted by Asian surgeons. Hepatogastroenterology. 2006;53:389-394.
20. Kunisaki C, Akiyama H, Nomura M, et al. Comparison of surgical results of D2 versus D3 gastrectomy (para-aortic lymph node dissection) for advanced gastric carcinoma: a multi-institutional study. Ann Surg Oncol. 2006;13:659-667.
21. Bijelic L, Sugarbaker PH. Cytoreduction of the small bowel surfaces. J Surg Oncol. 2007;97:176-179.
22. Weiss M, Voglic S, Harms-Schirra B, et al. Effects of exogenous recombinant human granulocyte colony-stimulating factor (filgrastim, rhG-CSF) on neutrophils of critically ill patients with systemic inflammatory response syndrome depend on endogenous G-CSF plasma concentrations on admission. Intensive Care Med. 2003;29:904-914.
23. Chua TC, Yan TD, Smigielski ME, et al. Long-term survival in patients with pseudomyxoma peritonei treated with cytoreductive surgery and perioperative intraperitoneal chemotherapy: 10 years experience from a single institution. Ann Surg Oncol. 2009;16:1903-1911.
24. Yu W, Whang I, Averbach A, et al. Morbidity and mortality of early postoperative intraperitoneal chemotherapy as adjuvant therapy for gastric cancer. Am Sur. 1998;64:1104-1108. (Pubitemid 28484098)
25. Stephens AD, Alderman R, Chang D, et al. Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol. 1999;6:790-796.
26. Chua TC, Yan TD, Saxena A, et al. Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure? A systematic review of morbidity and mortality. Ann Surg. 2009;249:900-907.
27. Winter JM, Cameron JL, Campbell KA, et al. 1423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg. 2006;10:1199-1210.
28. Pal N, Axisa B, Yusof S, et al. Volume and outcome for major upper GI surgery in England. J Gastrointest Surg. 2008;12:353-357.
29. Birkmeyer JD, Siewers AE, Finlayson EVA, et al. Hospital volume and surgical mortality in the United States. N Engl JMed. 2002;346:1128-1137.
30. Turaga K, Kaushik M, Forse RA, et al. In hospital outcomes after pancreatectomies: an analysis of a national database from 1996 to 2004. J Surg Oncol. 2008;98:156-160.